NEW YORK (GenomeWeb) – Scientists from Synthetic Genomics and the J. Craig Venter Institute have created a yeast-based platform for editing bacterial genomes using CRISPR/Cas9.

In a study published today in Scientific Reports, a team led by Venter and Daniel Gibson described how they engineered the small ribosomal subunit (16s) RNA of Mycoplasma mycoides, an essential gene for cell viability.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.